Prader-Willi syndrome is a rare genetic condition that brings unique challenges throughout a person’s life, from weak muscles and feeding problems in infancy to uncontrolled appetite and behavioral difficulties later on. Treatment doesn’t aim to cure the condition, but rather to control symptoms, prevent dangerous weight gain, support growth and development, and improve quality of life through careful medical care and lifestyle management.

How Medical Teams Approach Prader-Willi Syndrome Care

Treating Prader-Willi syndrome requires much more than just one doctor or one medication. The condition affects many parts of the body and behavior, so care teams usually include specialists from different fields working together. This team approach is considered essential for managing the complex symptoms that change as a person grows from infancy through adulthood.^[1]

The main goals of treatment are to help manage the constant hunger that develops in childhood, maintain a healthy weight, support normal growth and development, address hormone deficiencies, and help with behavioral and learning challenges. Because symptoms evolve over time, treatment plans must be adjusted regularly as the person with Prader-Willi syndrome moves through different life stages.^[2]

Currently, there is no cure for Prader-Willi syndrome. Treatment focuses on managing symptoms as they appear and preventing complications before they become serious. Early diagnosis and careful, lifelong management can significantly improve outcomes and quality of life for people living with this condition.^[12]

Standard Medical Treatments Used Every Day

Managing Feeding Problems in Infancy

Babies born with Prader-Willi syndrome face immediate feeding challenges. They have very weak muscles, which doctors call hypotonia, and this makes sucking and swallowing difficult. Many infants cannot breastfeed effectively and may need special feeding support. Some babies require feeding tubes that go through the nose and into the stomach to ensure they get enough nutrition in the first months of life.^[9]

After a few months, most babies can transition to normal bottle or breast feeding, although they may feed more slowly than other infants. Dietitians and speech therapists often work with families during this time to teach feeding techniques and recommend appropriate formulas or high-calorie feeds to help babies gain weight properly. This early intervention is crucial because infants with Prader-Willi syndrome can experience “failure to thrive” if their nutrition is not carefully monitored.^[11]

Growth Hormone Therapy

Growth hormone treatment represents one of the most significant advances in Prader-Willi syndrome care. In June 2000, the U.S. Food and Drug Administration approved the use of human growth hormone for children with genetically confirmed Prader-Willi syndrome who show evidence of growth failure.^[14]

Growth hormone does much more than just increase height. Studies have shown that it increases muscle mass while decreasing body fat, improves weight distribution across the body, increases stamina and energy levels, and strengthens bones by improving bone mineral density. Beyond physical benefits, research suggests it may also have positive effects on development and behavior in children with Prader-Willi syndrome.^[12]

Starting growth hormone therapy early in childhood, typically between six months and two years of age, appears to provide the best results. The treatment is usually given as daily injections and continued long-term. Doctors who specialize in hormones, called endocrinologists, oversee this therapy and adjust doses as needed. Guidelines developed by international experts in 2013 provide detailed recommendations for how growth hormone should be used in people with Prader-Willi syndrome.^[16]

Sex Hormone Replacement

Most people with Prader-Willi syndrome have underdeveloped genitals and delayed or incomplete puberty due to hormone deficiencies. Boys may have very small testicles that haven’t descended properly, sometimes requiring surgery in the first or second year of life. Both males and females typically produce very low levels of sex hormones.^[9]

Hormone replacement therapy may be recommended to support sexual development during adolescence. Males may receive testosterone, while females may be given estrogen and progesterone. This therapy helps with physical development, can improve bone strength, and may help with self-esteem and body image concerns. An endocrinologist will determine whether someone would benefit from hormone replacement and will monitor for any side effects.^[9]

Diet Management and Environmental Control

The most critical aspect of managing Prader-Willi syndrome is controlling food intake to prevent dangerous obesity. People with this condition have a lower metabolic rate than others, meaning their bodies burn fewer calories at rest. Combined with an uncontrollable appetite that typically begins between ages two and eight, this creates a constant risk of severe weight gain.^[1]

Unlike typical hunger, the appetite in Prader-Willi syndrome comes from a lack of feeling full or satisfied after eating, a condition called hyperphagia. The part of the brain that normally signals “you’ve had enough” doesn’t work properly. This means people with the condition will eat until food is no longer available, not because they feel hungry, but because they never receive the signal to stop.^[12]

A dietitian typically creates a specialized meal plan that is lower in calories than what would normally be recommended for someone of the same age and size. The diet emphasizes vegetables, salads, and other lower-calorie foods while limiting carbohydrates like potatoes, rice, and pasta. Sugary items, sweets, and high-calorie snacks must be strictly avoided from early childhood. Vitamin supplements are usually recommended to ensure nutritional needs are met despite the restricted diet.^[11]

Diet management requires significant environmental modifications. Families often need to lock kitchen cupboards, refrigerators, and even the entire kitchen to prevent access to food outside of scheduled meal times. Food should be kept completely out of view, and someone with Prader-Willi syndrome should never be left unsupervised where food might be accessible, including ensuring they cannot access garbage bins or freezers. Everyone who interacts with the person, including teachers, relatives, and friends, must understand and support these strict food restrictions.^[11]

Physical Activity Programs

Regular exercise is an essential part of treatment for maintaining a healthy weight and building muscle strength. Guidelines recommend that children with Prader-Willi syndrome get at least 60 minutes of physical activity daily. However, because people with this condition often have reduced energy levels and weak muscle tone, exercise programs need to be carefully designed.^[11]

Breaking exercise into shorter sessions of 5 to 10 minutes throughout the day can make it more manageable and prevent discouragement from fatigue. People with Prader-Willi syndrome often prefer individual activities over team sports. Swimming, walking, and exercising in a gym are popular choices that can be adapted to different ability levels. Care teams can help design appropriate exercise plans that match the person’s physical capabilities and interests.^[11]

Behavioral and Mental Health Support

Behavioral challenges are common in Prader-Willi syndrome and include temper tantrums, stubbornness, obsessive-compulsive behaviors like skin picking, and difficulty controlling emotions. These behaviors often intensify around food but can occur in other situations as well. Counseling and behavioral therapy help individuals and families develop strategies to manage these challenges.^[9]

Mental health professionals may recommend various approaches, including structured routines, clear rules and expectations, reward systems (though never using food as a reward), and techniques to redirect obsessive thoughts or behaviors. Some individuals may benefit from medications that help with mood, anxiety, or compulsive behaviors, though these are prescribed and monitored carefully by psychiatrists or other specialists.^[9]

Treating Other Medical Issues

People with Prader-Willi syndrome often develop additional health problems that require specific treatments. Many have sleep disorders including sleep apnea, where breathing repeatedly stops during sleep, and excessive daytime sleepiness. Sleep studies may be performed, and treatments might include special breathing machines at night or medications to improve alertness during the day.^[12]

Scoliosis, or curvature of the spine, is common and may require monitoring by orthopedic specialists. Some individuals need braces or, in severe cases, surgery to correct spinal problems. Dental care is particularly important because weak facial muscles and behavioral issues can make oral hygiene difficult. Regular dental checkups and preventive care help avoid serious tooth decay and gum disease.^[12]

Promising Treatments in Clinical Trials

Diazoxide Choline: The First Approved Drug for Hyperphagia

In March 2025, a significant breakthrough occurred when the U.S. Food and Drug Administration approved diazoxide choline, sold under the brand name Vykat XR, specifically for treating hyperphagia in Prader-Willi syndrome. This represents the first medication ever approved to address the constant hunger that is one of the most challenging and dangerous aspects of the condition.^[14]

The drug is approved for adults and children aged four years and older. The approval was based on a 16-week clinical trial that used a special design called a randomized withdrawal study. In this study, patients who had been taking diazoxide choline were randomly assigned to either continue the medication or switch to a placebo, an inactive pill. Researchers found that patients who switched to the placebo experienced a statistically significant worsening of their hyperphagia compared to those who stayed on the active drug. This demonstrated that diazoxide choline was helping to control the excessive appetite.^[14]

The mechanism of how diazoxide choline works involves affecting certain pathways in the body related to appetite regulation, though the full details of its action in Prader-Willi syndrome are still being studied. This approval marks an important milestone because, for the first time, doctors have a medication specifically designed and tested to help with one of the most difficult symptoms of Prader-Willi syndrome. However, the drug is still relatively new, and doctors are gaining experience with its long-term effects and optimal use in different patients.^[12]

Genetic Therapies Under Investigation

Researchers are exploring genetic therapy approaches that could potentially address the underlying genetic cause of Prader-Willi syndrome. The condition results from missing or non-functioning genes on chromosome 15, particularly a cluster of genes called SNORD116 that appear to play a major role in causing symptoms. Scientists are investigating whether it might be possible to replace or activate these missing genes.^[7]

Gene therapy for Prader-Willi syndrome is still in very early stages of research, mostly in laboratory settings and animal models. These experimental approaches involve using specially designed viruses or other delivery systems to carry working copies of genes into cells. While this research is promising, it will likely take many years before gene therapies are ready for testing in human clinical trials. The Foundation for Prader-Willi Research and other organizations maintain lists of therapies currently in development, which families can reference to stay informed about research progress.^[12]

Novel Appetite-Regulating Drugs

Several new anti-obesity medications that work by affecting appetite and metabolism pathways are being developed for the general population. Researchers are interested in whether some of these drugs might benefit people with Prader-Willi syndrome. These medications work through various mechanisms, such as mimicking hormones that signal fullness, affecting brain circuits that control eating behavior, or altering how the body processes nutrients.^[12]

Evaluating these drugs specifically in people with Prader-Willi syndrome is considered an important research priority. However, because the appetite dysfunction in Prader-Willi syndrome has a unique underlying cause related to hypothalamic dysfunction and genetic factors, medications that work for typical obesity may not necessarily be effective for this condition. Clinical trials testing these drugs in Prader-Willi syndrome patients are needed to determine which, if any, might help.^[12]

Understanding Clinical Trial Phases

When new treatments are being tested, they go through several phases of clinical trials before they can be approved for general use. Phase I trials focus primarily on safety, testing a new drug or treatment in a small group of people to evaluate side effects and determine safe dosing. Phase II trials involve more participants and aim to assess whether the treatment is effective for its intended purpose while continuing to monitor safety. Phase III trials are larger studies that compare the new treatment to standard treatments or placebo to confirm effectiveness, monitor side effects in a broader population, and gather information that will allow the treatment to be used safely.^[4]

For families interested in clinical trials for Prader-Willi syndrome, eligibility typically depends on factors such as the person’s age, genetic subtype of Prader-Willi syndrome, current health status, and sometimes whether they are taking certain other medications. Clinical trials may be conducted in various locations including the United States, Europe, and other regions worldwide. The Foundation for Prader-Willi Research maintains a registry and clinical trial consortium that helps connect researchers with potential participants.^[12]

Most common treatment methods

• Growth Hormone Therapy
  • Human growth hormone (HGH) given as daily injections to improve height, increase muscle mass, decrease body fat, and enhance energy levels
  • Typically started between 6 months and 2 years of age for best results
  • Continued long-term under supervision of an endocrinologist
  • Officially approved by the FDA in 2000 specifically for Prader-Willi syndrome
• Dietary Management
  • Low-calorie diet designed by dietitians with reduced carbohydrates and increased vegetables
  • Strict avoidance of sugary foods, sweets, and high-calorie snacks
  • Environmental controls including locked cupboards, refrigerators, and kitchens
  • Constant supervision during all food-related activities
  • Regular mealtimes with consistent portions
• Hormone Replacement Therapy
  • Testosterone for males to support development during adolescence
  • Estrogen and progesterone for females to promote sexual development
  • Helps with physical maturation, bone strength, and emotional well-being
  • Prescribed and monitored by endocrinologists
• Physical and Occupational Therapy
  • Early intervention therapies for infants to address muscle weakness and developmental delays
  • Ongoing physical therapy to build strength and coordination
  • Occupational therapy to develop daily living skills
  • Speech therapy for feeding difficulties and communication challenges
• Behavioral and Mental Health Treatment
  • Counseling to address emotional outbursts, stubbornness, and anxiety
  • Behavioral therapy to manage obsessive-compulsive behaviors and skin picking
  • Structured routines and clear expectations to reduce behavioral problems
  • Medications for mood, anxiety, or compulsive behaviors when needed
• Exercise Programs
  • At least 60 minutes of physical activity daily for children
  • Individual activities like swimming, walking, and gym exercises
  • Shorter exercise sessions throughout the day to prevent fatigue
  • Tailored programs matching individual abilities and interests
• Appetite Control Medication
  • Diazoxide choline (Vykat XR) approved in March 2025 for treating hyperphagia
  • First medication specifically approved for hunger control in Prader-Willi syndrome
  • Approved for adults and children aged 4 years and older
  • Tested in clinical trials showing improvement in excessive appetite symptoms